Escola de Veterinária, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
Pontifícia Universidade Católica de Minas Gerais (PUC Minas), Betim, MG, Brazil.
J Equine Vet Sci. 2020 Nov;94:103233. doi: 10.1016/j.jevs.2020.103233. Epub 2020 Aug 25.
The aim of this study was to evaluate the effect of equine chorionic gonadotropin (eCG) at the end of progesterone (P4) treatment on follicular and luteal characteristics during transition period (TP) and reproductive breeding season (RP). A total of 13 crossbred mares were distributed in two experimental groups in the spring and summer (n = 26). The animals received intravaginal P4 (1.9 g) releasing device from D0 to D10. On removal of P4 device, the mares received 400 IU of eCG (eCG group) or saline solution (control group). Human chorionic gonadotropin (hCG; 1.750 IU) was administered (DhCG) as soon as ovulatory follicle (OF) ≥35 mm was detected. Ovarian ultrasonography was performed from D0 until 15 days after ovulation. Blood samples were collected on D0, D5, D10, DhCG, 9 days after ovulation (CL9D), and 13 days after ovulation (CL13D). P4 and estradiol concentrations were assessed by chemiluminescence. Data were compared by Tukey test at P < .05. Ovulation rate was similar (P = .096) between seasons (RP = 100%; TP = 70%) but occurred earlier (P = .015) in RP (34.8 ± 10.1 hours) compared with TP (42.0 ± 10.4 hours). Interactions between season and treatment were observed for OF diameter (mm) (RP/control = 36.2 ± 1.8ab; RP/eCG = 32.9 ± 2.8 b; TP/control = 32.2 ± 1.2 b; TP/eCG = 37.2 ± 1.9a; P = .004) and for corpus luteum (CL) diameter (mm) on CL13D (RP/control = 25.4 ± 3.5a; RP/eCG = 22.5 ± 1.8ab; TP/control = 21.6 ± 4.9 b; TP/eCG = 27.4 ± 4.3a; P = .023), although no differences were observed for serum P4 on CL13D (RP/control = 6.0 ± 3.1 ng/mL; RP/eCG = 5.8 ± 0.9 ng/mL; TP/control = 3.6 ± 2.7 ng/mL; TP/eCG = 5.1 ± 2.3 ng/mL; P = .429) or for day of structural CL regression (RP/control = 12.8 ± 1.9; RP/eCG = 12.1 ± 1.1; TP/control = 11.0 ± 1.7; TP/eCG = 13.2 ± 2.0; P = .102). The application of eCG at the moment of P4 implant removal seemed to increase the capacity of luteal maintenance during spring TP. However, eCG treatment was worthless during the breeding season.
本研究旨在评估在孕酮(P4)治疗结束时给予马绒毛膜促性腺激素(eCG)对过渡时期(TP)和繁殖季节(RP)中卵泡和黄体特征的影响。共有 13 匹杂交母马在春季和夏季(n=26)被分配到两个实验组。动物从 D0 至 D10 接受阴道内 P4(1.9 g)释放装置。去除 P4 装置后,母马接受 400 IU eCG(eCG 组)或生理盐水溶液(对照组)。一旦排卵卵泡(OF)≥35 mm,即给予人绒毛膜促性腺激素(hCG;1.750 IU)(DhCG)。从 D0 至排卵后 15 天进行卵巢超声检查。在 D0、D5、D10、DhCG、排卵后 9 天(CL9D)和排卵后 13 天(CL13D)采集血液样本。通过化学发光法评估 P4 和雌二醇浓度。数据通过 Tukey 检验在 P<0.05 时进行比较。季节之间的排卵率相似(P=0.096)(RP=100%;TP=70%),但在 RP(34.8±10.1 小时)中比 TP(42.0±10.4 小时)更早发生(P=0.015)。OF 直径(mm)(RP/control=36.2±1.8ab;RP/eCG=32.9±2.8b;TP/control=32.2±1.2b;TP/eCG=37.2±1.9a;P=0.004)和黄体直径(mm)在 CL13D 时(RP/control=25.4±3.5a;RP/eCG=22.5±1.8ab;TP/control=21.6±4.9b;TP/eCG=27.4±4.3a;P=0.023)观察到季节和处理之间的相互作用,尽管在 CL13D 时血清 P4 没有差异(RP/control=6.0±3.1ng/mL;RP/eCG=5.8±0.9ng/mL;TP/control=3.6±2.7ng/mL;TP/eCG=5.1±2.3ng/mL;P=0.429)或黄体结构退化的天数(RP/control=12.8±1.9;RP/eCG=12.1±1.1;TP/control=11.0±1.7;TP/eCG=13.2±2.0;P=0.102)。在 P4 植入物去除时给予 eCG 似乎增加了春季 TP 期间黄体维持的能力。然而,在繁殖季节,eCG 治疗毫无价值。